Referencer - Behandlingsvejledning

1. Schwenkhagen AM, Stodieck SR. Which contraception for women with epilepsy?Seizure. 2008;17(2):145-50.
2. Sabers A. Algorithm for lamotrigine dose adjustment before, during, and afterpregnancy. Acta Neurol Scand. 2012;126(1):e1-4.
3. Christensen J, Petrenaite V, Atterman J, Sidenius P, Ohman I, Tomson T, et al.Oralcontraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlledtrial. Epilepsia. 2007;48(3):484-9.
4. Starck C, Nevalainen O, Auvinen A, Eriksson K. Fertility and marital status in adultswith childhood onset epilepsy: A population-based cohort study.Epilepsia. 2019;60(7):1438-44.
5. Pennell PB, French JA, Harden CL, Davis A, Bagiella E, Andreopoulos E, et al.Fertilityand Birth Outcomes in Women With Epilepsy Seeking Pregnancy. JAMA Neurol. 2018;75(8):962-9.
6. Stephen LJ, Harden C, Tomson T, Brodie MJ. Management of epilepsy in women.Lancet Neurol. 2019;18(5):481-91.
7. Tomson T, Battino D, Bromley R,Kochen S, Meador K, Pennell P, et al. Managementof epilepsy in pregnancy: a report from the International League Against Epilepsy Task Force onWomen and Pregnancy. Epileptic Disord. 2019;21(6):497-517.
8. Tomson T, Battino D, Perucca E. Teratogenicity ofantiepileptic drugs. Curr OpinNeurol. 2019;32(2):246-52.
9. Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, et al. Comparativerisk of major congenital malformations with eight different antiepileptic drugs: a prospectivecohort study of the EURAP registry.Lancet Neurol.2018;17(6):530-8.
10. Harden CL, Pennell PB, Koppel BS, Hovinga CA, Gidal B, Meador KJ, et al.Management issues for women with epilepsy--focus on pregnancy (an evidence-based review): III.Vitamin K, folic acid, bloodlevels, and breast-feeding: Report of the Quality StandardsSubcommittee and Therapeutics and Technology Assessment Subcommittee of the AmericanAcademy of Neurology and the American Epilepsy Society. Epilepsia. 2009;50(5):1247-55.
11. Field MS, Stover PJ.Safety of folic acid. Ann N Y Acad Sci. 2018;1414(1):59-71.
12. McNulty H, Rollins M, Cassidy T, Caffrey A, Marshall B, Dornan J, et al. Effect ofcontinued folic acid supplementation beyond the first trimester of pregnancy on cognitiveperformance in thechild: a follow-up study from a randomized controlled trial (FASSTT OffspringTrial). BMC Med. 2019;17(1):196.
13. Valera-Gran D, Navarrete-Munoz EM, Garcia de la Hera M, Fernandez-Somoano A,Tardon A, Ibarluzea J, et al. Effect of maternal high dosages of folic acid supplements onneurocognitive development in children at 4-5 y of age: the prospective birth cohort Infancia yMedio Ambiente (INMA) study. Am J Clin Nutr. 2017;106(3):878-87.
14. Nei M, Daly S, Liporace J. A maternal complex partial seizure in labor can affect fetalheart rate. Neurology. 1998;51(3):904-6.
15. Sveberg L, Svalheim S, Tauboll E. The impact of seizures on pregnancy and delivery.Seizure. 2015;28:35-8.
16. Katz JM, Devinsky O. Primary generalized epilepsy: a risk factor for seizures in laborand delivery? Seizure. 2003;12(4):217-9.
17. Puckett RM, Offringa M. Prophylactic vitamin K for vitamin K deficiency bleeding inneonates. Cochrane Database Syst Rev. 2000(4):CD002776.
18. Yamasmit W, Chaithongwongwatthana S, Tolosa JE. Prenatal vitamin K1administration in epileptic women to prevent neonatal hemorrhage: is it effective? J Reprod Med.2006;51(6):463-6.
19. Kaaja E, Kaaja R, Matila R, Hiilesmaa V. Enzyme-inducing antiepileptic drugs inpregnancy and the risk of bleeding in the neonate. Neurology. 2002;58(4):549-53.
20. Veiby G, Daltveit AK, Schjolberg S, Stoltenberg C, Oyen AS, Vollset SE, et al. Exposureto antiepileptic drugs in utero and child development: a prospective population-based study.Epilepsia. 2013;54(8):1462-72.
21. Veiby G, Bjork M, Engelsen BA, Gilhus NE. Epilepsy and recommendations forbreastfeeding.Seizure. 2015;28:57-65.